Advanced molecular discovery and characterisation facility

先进的分子发现和表征设施

• 批准号: LE100100226
• 负责人: Prof Richard Lewis
• 金额: $ 28.27万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Infrastructure, Equipment and Facilities
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-07-31 至 2011-08-26
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LE100100226
• 关键词: Advanced; molecular; discovery; characterisation; facility

Natural product drug discovery in Australia requires access to high throughput functional assays to guide the separation and of novel bioactives with therapeutic potential. By establishing the advanced molecular discovery and characterisation facility in an academic environment across two institutions, research programs in early drug lead discovery and characterisation will be accelerated. It will provide unique capabilities not currently available in Australia, and help Australian researchers remain internationally competitive in breakthrough science and frontier technologies. The research enabled by this facility will lead to development of new drug candidates by the emerging Australian biotechnology industry.

澳大利亚的天然产物药物发现需要高通量功能测定来指导具有治疗潜力的新型生物活性物质的分离和开发。通过在两个机构的学术环境中建立先进的分子发现和表征设施，将加速早期药物先导发现和表征的研究计划。它将提供澳大利亚目前没有的独特能力，并帮助澳大利亚研究人员在突破性科学和前沿技术方面保持国际竞争力。该设施的研究将导致澳大利亚新兴生物技术产业开发新的候选药物。